| Literature DB >> 32821512 |
Josh Tjunrong Sia1, Alfred Tau Liang Gan2, BaoLin Pauline Soh2, Eva Fenwick2,3, Joanne Quah4,5, Thakur Sahil2, Yijin Tao2,6, Ngiap Chuan Tan4,5, Charumathi Sabanayagam2,3, Ecosse L Lamoureux2,3,7, Ryan Eyn Kidd Man2,3.
Abstract
Purpose: To determine the rates and develop an initial risk prediction model for nonadherence to post screening ophthalmic referral (PSOR) in type 2 diabetes mellitus (T2DM) patients attending a national diabetic retinopathy screening program in Singapore.Entities:
Keywords: diabetes; eye screening; public health; referable eye disease
Mesh:
Year: 2020 PMID: 32821512 PMCID: PMC7408802 DOI: 10.1167/tvst.9.6.15
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.283
Patients’ Sociodemographic and Clinical Characteristics Stratified by Adherence to PSOR (N = 2421)
| Mean (SD)/N (%) | |||
|---|---|---|---|
| Variable | Adherent (n = 2114) | Nonadherent (n = 307) |
|
| Age (years) | 66.6 (11.1) | 66.0 (9.8) | 0.190 |
| BMI (kg/m2) | 25.7 (4.5) | 26.3 (4.7) |
|
| Diabetes duration (years) | 7.5 (6.0) | 7.3 (5.9) | 0.639 |
| SBP (mm Hg) | 132.3 (18.2) | 129.6 (17.7) |
|
| DBP (mm Hg) | 69.9 (10.6) | 69.4 (10.4) | 0.530 |
| HbA1c (%) | 7.4 (1.6) | 7.1 (1.3) |
|
| Total cholesterol (mmol/L) | 4.5 (1.0) | 4.5 (0.9) | 0.948 |
| HDL cholesterol (mmol/L) | 1.4 (0.4) | 1.4 (0.4) | 0.058 |
| LDL cholesterol (mmol/L) | 2.5 (0.8) | 2.4 (0.8) | 0.152 |
| Triglyceride (mmol/L) | 1.5 (1.1) | 1.5 (0.7) | 0.163 |
| Creatinine (mmol/L) | 86.1 (38.4) | 83.3 (39.2) | 0.062 |
| Presenting VA in better eye (logMAR) | |||
| Presenting VA in worse eye (logMAR) | 0.5 (0.5) | 0.4 (0.3) |
|
| Female | 1111 (52.6) | 160 (52.1) | 0.903 |
| Race | |||
| Malay | 159 (7.5) | 19 (6.2) | 0.222 |
| Indian | 235 (11.1) | 46 (15.0) | |
| Chinese | 1670 (79.0) | 234 (76.2) | |
| Others | 50 (2.4) | 8 (2.6) | |
| DR severity | |||
| No DR | 1362 (64.4) | 258 (84.0) |
|
| Mild DR | 376 (17.8) | 30 (9.8) | |
| Moderate DR | 245 (11.6) | 9 (2.9) | |
| Severe DR | 105 (5.0) | 7 (2.3) | |
| Proliferative DR | 26 (1.2) | 3 (1.0) | |
| DME | 345 (16.3) | 13 (4.2) |
|
| Glaucoma | 270 (12.8) | 9 (2.9) |
|
| AMD | 203 (9.6) | 9 (2.9) |
|
| Cataract | 608 (28.8) | 35 (11.4) |
|
| Other eye condition | 590 (27.9) | 26 (8.5) |
|
| Two or more eye conditions | 490 (23.2) | 23 (7.5) |
|
| Antihypertensive medication use | 1843 (87.3) | 268 (87.6) | 1.000 |
| Anticholesterol medication use | 1817 (86.1) | 271 (88.6) | 0.248 |
| Antidiabetic medication use | 1669 (79.1) | 225 (73.5) |
|
Mann-Whitney U test or the Fisher's exact test. Bold indicates statistically significant results (P < 0.05).
Multivariable-Adjusted Predictors of Nonadherence to PSOR (N = 2421)
| Variable | RR (95% CI) |
|
|---|---|---|
| Age (years) | 0.99 (0.98–1.01) | 0.320 |
| Female | 0.93 (0.76–1.15) | 0.509 |
| BMI (kg/m2) | 1.01 (0.99–1.03) | 0.438 |
| Race | ||
| Chinese | Reference | |
| Indian | 1.12 (0.87–1.44) | 0.390 |
| Malay | 1.10 (0.72–1.68) | 0.651 |
| Others | 1.12 (0.69–1.83) | 0.639 |
| SBP (mm Hg) | 1.00 (0.99–1.00) | 0.725 |
| HbA1c (%) | 0.94 (0.86–1.03) | 0.179 |
| HDL cholesterol (mmol/L) | 1.27 (0.99–1.62) | 0.058 |
| LDL cholesterol (mmol/L) | 0.97 (0.85–1.11) | 0.667 |
| Triglyceride (mmol/L) | 1.07 (1.01–1.13) |
|
| Creatinine (mmol/L) | 1.00 (1.00–1.01) | 0.527 |
| Presenting VA in worse eye (logMAR) | 0.98 (0.92–1.03) | 0.397 |
| DR severity | ||
| No DR | Reference | |
| Mild DR | 0.58 (0.36–0.93) |
|
| Moderate DR | 0.10 (0.05–0.20) |
|
| Severe DR | 0.27 (0.13–0.57) |
|
| Proliferative DR | 0.43 (0.15–1.28) | 0.131 |
| DME | 0.20 (0.09–0.43) |
|
| Glaucoma | 0.09 (0.04–0.17) |
|
| AMD | 0.12 (0.06–0.24) |
|
| Cataract | 0.16 (0.11–0.23) |
|
| Other eye condition | 0.15 (0.10–0.22) |
|
| Two or more eye conditions | 0.28 (0.19–0.41) |
|
| Antihypertensive medication use | 1.11 (0.84–1.49) | 0.462 |
| Anticholesterol medication use | 1.04 (0.76–1.44) | 0.790 |
| Antidiabetic medication use | 0.86 (0.69–1.07) | 0.187 |
Substitutes for the six individual eye conditions in the multivariable model. Bolded values indicate statistically significant results (P < 0.05).
The AUC for Various Models in Prediction of Nonadherence to PSOR
| Model | Description | AUC (95% CI) |
|---|---|---|
| 1 | Base | 0.64 (0.61–0.67) |
| 2 | Plus DR severity | 0.69 (0.66–0.72) |
| 3 | Plus DME | 0.68 (0.64–0.71) |
| 4 | Plus glaucoma | 0.68 (0.65–0.71) |
| 5 | Plus AMD | 0.67 (0.63–0.70) |
| 6 | Plus cataract | 0.68 (0.65–0.71) |
| 7 | Plus other eye condition | 0.68 (0.65–0.71) |
| 8 | Plus all six eye conditions | 0.84 (0.81–0.87) |
| 9 | Plus two or more eye conditions | 0.70 (0.67–0.73) |
| 10 | Plus all six eye conditions and two or more eye conditions | 0.84 (0.81–0.87) |
| 11 | Conditional inference regression tree | 0.84 (0.81–0.86) |
Modified Poisson model adjusted for age, sex, BMI, SBP, triglycerides, and worse eye presenting VA.
The AUC for model 8 was significantly higher than models 1–7, and 9.
AUCs for all models was significantly higher than the base model.
Figure.Conditional inference tree for the prediction of non-adherence to PSOR (N = 2421 visits). The dataset is successively split (from top right to bottom left) in order of the predictor variable that produces the largest significant difference in an asymptotic test statistic comparing non-adherence between the split groups. The tree has a total of 7 branches (B1 to B7) and ovals contain the splitting variable at each branch and the corresponding Bonferroni-corrected P-value for the split. Rectangular boxes are terminal nodes of the tree that patients are exclusively classified into. N refers to the number of patients in each node and the prevalence of non-adherence to PSOR is given adjacent within parentheses. For example, a patient with AMD and no other referable eye conditions would move downwards (southwesterly) the tree and be siphoned out at the sixth branch into the AMD node, with an estimated non-adherence probability of 3.2%.